Patrick J Mahaffy - Net Worth and Insider Trading

Patrick J Mahaffy Net Worth

The estimated net worth of Patrick J Mahaffy is at least $14,562 dollars as of 2024-05-24. Patrick J Mahaffy is the President and CEO of Clovis Oncology Inc and owns about 970,787 shares of Clovis Oncology Inc (CLVSQ) stock worth over $14,562. Details can be seen in Patrick J Mahaffy's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Patrick J Mahaffy has not made any transactions after 2019-08-16 and currently still holds the listed stock(s).

Transaction Summary of Patrick J Mahaffy

To

Patrick J Mahaffy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick J Mahaffy owns 3 companies in total, including Flexion Therapeutics Inc (FLXN) , Clovis Oncology Inc (CLVSQ) , and Orexigen Therapeutics Inc (OREXQ) .

Click here to see the complete history of Patrick J Mahaffy’s form 4 insider trades.

Insider Ownership Summary of Patrick J Mahaffy

Ticker Comapny Transaction Date Type of Owner
FLXN Flexion Therapeutics Inc 2020-06-10 director
CLVSQ Clovis Oncology Inc 2019-08-16 director & President and CEO
OREXQ Orexigen Therapeutics Inc 2017-07-14 director

Patrick J Mahaffy Latest Holdings Summary

Patrick J Mahaffy currently owns a total of 1 stock. Patrick J Mahaffy owns 970,787 shares of Clovis Oncology Inc (CLVSQ) as of August 16, 2019, with a value of $14,562.

Latest Holdings of Patrick J Mahaffy

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CLVSQ Clovis Oncology Inc 2019-08-16 970,787 0.02 14,562

Holding Weightings of Patrick J Mahaffy


Patrick J Mahaffy Form 4 Trading Tracker

According to the SEC Form 4 filings, Patrick J Mahaffy has made a total of 1 transactions in Clovis Oncology Inc (CLVSQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Clovis Oncology Inc is the acquisition of 50,000 shares on August 16, 2019, which cost Patrick J Mahaffy around $279,500.

Insider Trading History of Patrick J Mahaffy

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Patrick J Mahaffy Trading Performance

GuruFocus tracks the stock performance after each of Patrick J Mahaffy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick J Mahaffy is 51.43%. GuruFocus also compares Patrick J Mahaffy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick J Mahaffy within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Patrick J Mahaffy's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Patrick J Mahaffy

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.27
Relative Return to S&P 500(%) 1.25

Patrick J Mahaffy Ownership Network

Ownership Network List of Patrick J Mahaffy

No Data

Ownership Network Relation of Patrick J Mahaffy


Patrick J Mahaffy Owned Company Details

What does Flexion Therapeutics Inc do?

Who are the key executives at Flexion Therapeutics Inc?

Patrick J Mahaffy is the director of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , General Counsel Mark S. Levine , and Chief Strategy Officer Christina Willwerth .

Flexion Therapeutics Inc (FLXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Flexion Therapeutics Inc Insider Transactions

No Available Data

Patrick J Mahaffy Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick J Mahaffy. You might contact Patrick J Mahaffy via mailing address: C/o Clovis Oncology, Inc., 5500 Flatiron Parkway, Suite 100, Boulder Co 80301.

Discussions on Patrick J Mahaffy

No discussions yet.